(MENAFN- Ameliorate Digital Consultancy)
The 3d microfluidic organ chip market outlook looks extremely promising is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain, future roadmaps and strategies. This Market study provides comprehensive data that enhances the understanding, scope, and application of this report. Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche 3D Microfluidic Organ Chip are aligned with your aims.
The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro-overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the 3D Microfluidic Organ Chip market covering all its essential aspects.
Get FREE Sample Copy of this Report :
Top Leading Companies of Global 3D Microfluidic Organ Chip Market are Emulate, TissUse, Hesperos, CN Bio Innovations, Tara Biosystems, Draper Laboratory, Mimetas, Nortis, Micronit Microtechnologies B.V., Kirkstall, Cherry Biotech SAS, Else Kooi Laboratory,
The global 3d microfluidic organ chip market was valued at $103.44 million in 2021, and is projected to reach $ 1.6 billion by 2029, growing at a CAGR of 31.1% from 2022 to 2029.
recent development :
December 06 2022 , BOSTON–Emulate, Inc., the leading provider of next-generation in vitro models, today announced the publication of a landmark study,“Performance assessment and economic analysis of a human Liver-Chip for predictive toxicology,” in Nature Communications Medicine demonstrating that the Emulate human Liver-Chip could improve patient safety and reduce small-molecule clinical trial failures due to liver toxicity by up to 87%.
April 19, 2022 , ORLANDO, Fla.–Hesperos Inc., pioneers of Human-on-a-Chip in vitro systems, today announced the publication of a peer-reviewed article showing that a Human-on-a-Chip® (HoaC) cell-based system recapitulates the neurophysiological characteristics of two rare autoimmune demyelinating neuropathies and demonstrate its potential use to evaluate novel therapeutics. These results support the use of in vitro, microphysiological systems (MPS) to bridge the gap between pre-clinical models and patients. The manuscript, titled“Classical Complement Pathway Inhibition in a 'Human-on-a-Chip' Model of Autoimmune Demyelinating Neuropathies” was published in Advanced Therapeutics.
Market Segmentation :
By Types :
Brain-on-a-chip
Liver-on-a-chip
Kidney-on-a-chip
Others
By Application
Hospital
Biotechnology
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2023-2029) of the following regions are covered
North America is anticipated to dominate the market over the period. The United States has the greatest market share in the North American area, because of rising R&D spending on drug discovery and biotechnology. It dominates the organ-on-chip market, owing to factors such as the availability of a wide range of services offered by major players which include customized designing of new chips with specific organ arrangements and an increase in toxicological testing of chemicals on the different types of organ cells. Huge investments are being made by public and private institutes for their research.
Some of the key questions answered in this report
-What is the market size, share of the market?
-Who are the top market players operating in the 3D Microfluidic Organ Chip market?
-What are sales, revenue, and price analysis by regions of industries?
-What are the modes and strategic moves considered suitable for entering the global 3D Microfluidic Organ Chip market?
-What are the leading trends that are completely impacting the growth of the market?
-What were the pre-and post-business impacts of Covid-19 on the 3D Microfluidic Organ Chip Market?
Browse Full Report for TOC and Description:
Detailed TOC of Global 3D Microfluidic Organ Chip Market Insights and Forecast to 2028
Chapter 1 : Introduction, market driving force product Objective of Study and Research Scope the 3D Microfluidic Organ Chip market
Chapter 2 : Exclusive Summary – the basic information of the 3D Microfluidic Organ Chip Market.
Chapter 3 : Displaying the Market Dynamics- Drivers, Trends and Challenges & Opportunities of the 3D Microfluidic Organ Chip
Chapter 4 : Presenting the 3D Microfluidic Organ Chip Market Factor Analysis, Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.
Chapter 5 : Displaying the by Type, End User and Region/Country 2015-2020
Chapter 6 : Evaluating the leading manufacturers of the 3D Microfluidic Organ Chip market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile
Chapter 7 : To evaluate the market by segments, by countries and by Manufacturers/Company with revenue share and sales by key countries in these various regions (2022-2027)
Chapter 8 & 9 : Displaying the Appendix, Methodology and Data Source
Reasons for Buying this Report
-This report provides pin-point analysis for changing competitive dynamics
-It provides a forward-looking perspective on different factors driving or restraining market growth
-It provides a six-year forecast assessed on the basis of how the market is predicted to grow
-It helps in understanding the key product segments and their future
-It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
-It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
Finally, the 3D Microfluidic Organ Chip Market report is the believable source for gaining the market research that will exponentially accelerate your business. The report gives the principle locale, economic situations with the item value, benefit, limit, generation, supply, request, and market development rate and figure, and so on. The 3D Microfluidic Organ Chip industry report additionally presents a new task SWOT examination, speculation attainability investigation, and venture return investigation.
Final Report will add the analysis of the impact of COVID-19 on this industry; Buy now@
Customization of the report:
10-year forecast to help you make strategic decisions In-depth segmentation which can be customized as per your requirements Free consultation with lead analyst of the report Excel data pack included with all report purchases Robust and transparent research methodology
Contact Us:
Irfan Tamboli (Head of Sales) – Market Insights Reports
Phone: + 1704 266 3234 | +91-750-707-8687
|